- Home
- ADAP vs ORGN Comparison
ADAP vs ORGN Comparison
Compare ADAP & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- ORGN
- Stock Information
- Founded
- ADAP 2008
- ORGN 2008
- Country
- ADAP United Kingdom
- ORGN United States
- Employees
- ADAP N/A
- ORGN N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- ORGN Major Chemicals
- Sector
- ADAP Health Care
- ORGN Industrials
- Exchange
- ADAP Nasdaq
- ORGN Nasdaq
- Market Cap
- ADAP 71.6M
- ORGN 83.0M
- IPO Year
- ADAP 2015
- ORGN N/A
- Fundamental
- Price
- ADAP $0.24
- ORGN $0.60
- Analyst Decision
- ADAP Strong Buy
- ORGN Strong Buy
- Analyst Count
- ADAP 5
- ORGN 1
- Target Price
- ADAP $1.83
- ORGN $3.00
- AVG Volume (30 Days)
- ADAP 2.6M
- ORGN 1.1M
- Earning Date
- ADAP 05-14-2025
- ORGN 05-13-2025
- Dividend Yield
- ADAP N/A
- ORGN N/A
- EPS Growth
- ADAP N/A
- ORGN N/A
- EPS
- ADAP N/A
- ORGN N/A
- Revenue
- ADAP $178,032,000.00
- ORGN $31,282,000.00
- Revenue This Year
- ADAP N/A
- ORGN $83.02
- Revenue Next Year
- ADAP $65.49
- ORGN $24.18
- P/E Ratio
- ADAP N/A
- ORGN N/A
- Revenue Growth
- ADAP 195.34
- ORGN 8.60
- 52 Week Low
- ADAP $0.20
- ORGN $0.42
- 52 Week High
- ADAP $1.48
- ORGN $1.90
- Technical
- Relative Strength Index (RSI)
- ADAP 37.78
- ORGN 40.65
- Support Level
- ADAP $0.23
- ORGN $0.52
- Resistance Level
- ADAP $0.26
- ORGN $0.65
- Average True Range (ATR)
- ADAP 0.04
- ORGN 0.06
- MACD
- ADAP 0.01
- ORGN 0.01
- Stochastic Oscillator
- ADAP 31.85
- ORGN 62.67
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.